The researchers designed the device to work seamlessly with existing medical imaging technologies, including ultrasound and CT scans.
The capsule uses advanced light-absorption technology to detect blood in the upper gastrointestinal tract and wirelessly transmits the findings to an external receiver, which is monitored by healthcare professionals.
Abbott’s Determine™ ANC Panel enables simultaneous detection of HIV, syphilis, and hepatitis B from a single finger-prick sample, delivering results within minutes at the point of care.
The publications aim to support the growing integration of AI into medical imaging and to strengthen clinicians’ ability to use these technologies safely and effectively in everyday practice.
Under the agreement, EGT will oversee the rollout of Koios DS™ Breast and Koios DS™ Thyroid across key GCC markets, including the United Arab Emirates, Saudi Arabia, and Qatar.
The newly introduced AI algorithm performs measurements that radiologists previously conducted manually, significantly reducing interpretation time and improving consistency in diagnosis.
Since 2020, the Moscow government has been running the Moscow Experiment on Computer Vision in healthcare, an initiative coordinated by the Center for Diagnostics and Telemedicine with support from the city’s digital infrastructure teams.
The Bundibugyo strain remains particularly challenging because no approved vaccine or specific treatment is currently available.
The approval strengthens Abbott’s position in the continuous glucose monitoring (CGM) market and expands its diagnostic capabilities beyond glucose-only tracking, which has traditionally defined wearable diabetes management tools.
The facility, which is expected to begin operations in 2027, will become Align Technology’s first manufacturing site in India and its fourth worldwide.